NCT00330902View on ClinicalTrials.gov

Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudan

PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

November 30, 2004

Conditions
Plasmodium Infections
Interventions
DRUG

sulfadoxine-pyrimethamine (SP) plus artesunate (AS)

sulfadoxine-pyrimethamine (SP) plus three daily doses of artesunate (AS)

DRUG

primaquine (PQ) plus SP+AS

single dose of primaquine on day 4

Trial Locations (1)

Unknown

Tropical Medicine Research Institute, Khartoum

All Listed Sponsors
collaborator

Tropical Medicine Research Institute

OTHER

collaborator

World Health Organization

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00330902 - Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudan | Biotech Hunter | Biotech Hunter